Included in the Neurology Department of the University Hospital of Nice, the center is totally devoted to the care of patients with ALS and other rare motor neuron diseases with specific in and out-patients facilities and dedicated team. Medical staff includes neurologist, pulmonologist and physical rehabilitation specialists with formal connections with nutritionists and palliative care teams. A multi professional team of 8 paramedical, administrative, psychologist, social worker and CRA is attached, in relation with a formal devoted local network to ensure the follow-up with residence and home-care professionals.
In the COURAGE-ALS study, we are investigating the efficacy and safety of the drug ‘reldesemtiv’ for the treatment of ALS. This clinical trial is sponsored by Cytokinetics.
Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS).